Found: 25
Select item for more details and to access through your institution.
Predicting overall survival from tumor dynamics metrics using parametric statistical and machine learning models: application to patients with RET-altered solid tumors.
- Published in:
- Frontiers in Artificial Intelligence, 2024, p. 1, doi. 10.3389/frai.2024.1412865
- By:
- Publication type:
- Article
Population Pharmacokinetics and Exposure‐Response Analysis of nab‐Paclitaxel in Pediatric Patients With Recurrent or Refractory Solid Tumors.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 2, p. 115, doi. 10.1002/cpdd.803
- By:
- Publication type:
- Article
Machine Learning for Exposure-Response Analysis: Methodological Considerations and Confirmation of Their Importance via Computational Experimentations.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 5, p. 1381, doi. 10.3390/pharmaceutics15051381
- By:
- Publication type:
- Article
Population-Based Pharmacodynamic Modeling of Omalizumab in Pediatric Patients with Moderate to Severe Persistent Inadequately Controlled Allergic Asthma.
- Published in:
- AAPS Journal, 2023, v. 25, n. 4, p. 1, doi. 10.1208/s12248-023-00823-4
- By:
- Publication type:
- Article
Incorporation of GSTA1 genetic variations into a population pharmacokinetic model for IV busulfan in paediatric hematopoietic stem cell transplantation.
- Published in:
- British Journal of Clinical Pharmacology, 2018, v. 84, n. 7, p. 1494, doi. 10.1111/bcp.13566
- By:
- Publication type:
- Article
Population pharmacokinetics and Bayesian estimation of tacrolimus exposure in paediatric liver transplant recipients.
- Published in:
- British Journal of Clinical Pharmacology, 2014, v. 77, n. 6, p. 1051, doi. 10.1111/bcp.12276
- By:
- Publication type:
- Article
Population pharmacokinetic and exposure–response analysis of apremilast in Japanese subjects with moderate to severe psoriasis.
- Published in:
- Journal of Dermatology, 2021, v. 48, n. 11, p. 1652, doi. 10.1111/1346-8138.16068
- By:
- Publication type:
- Article
Machine Learning‐Based Quantification of Patient Factors Impacting Remission in Patients With Ulcerative Colitis: Insights from Etrolizumab Phase III Clinical Trials.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 4, p. 815, doi. 10.1002/cpt.3076
- By:
- Publication type:
- Article
External validation of a tumor growth inhibition-overall survival model in non-small-cell lung cancer based on atezolizumab studies using alectinib data.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2023, v. 92, n. 3, p. 205, doi. 10.1007/s00280-023-04558-z
- By:
- Publication type:
- Article
Population pharmacokinetics and exposure-response of trametinib, a MEK inhibitor, in patients with BRAF V600 mutation-positive melanoma.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Understanding CYP3A4 and P‐gp mediated drug–drug interactions through PBPK modeling – Case example of pralsetinib.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 4, p. 660, doi. 10.1002/psp4.13114
- By:
- Publication type:
- Article
Population pharmacokinetic analysis of etrolizumab in patients with moderately‐to‐severely active ulcerative colitis.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2022, v. 11, n. 9, p. 1244, doi. 10.1002/psp4.12846
- By:
- Publication type:
- Article
Exposure‐response relationships of etrolizumab in patients with moderately‐to‐severely active ulcerative colitis.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2022, v. 11, n. 9, p. 1234, doi. 10.1002/psp4.12840
- By:
- Publication type:
- Article
Precision dosing of intravenous busulfan in pediatric hematopoietic stem cell transplantation: Results from a multicenter population pharmacokinetic study.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2021, v. 10, n. 9, p. 1043, doi. 10.1002/psp4.12683
- By:
- Publication type:
- Article
Population Pharmacokinetics and Exposure–Response of Luspatercept, an Erythroid Maturation Agent, in Anemic Patients With Myelodysplastic Syndromes.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2020, v. 9, n. 7, p. 395, doi. 10.1002/psp4.12521
- By:
- Publication type:
- Article
Conversion from twice- to once-daily tacrolimus in pediatric kidney recipients: a pharmacokinetic and bioequivalence study.
- Published in:
- Pediatric Nephrology, 2014, v. 29, n. 6, p. 1081, doi. 10.1007/s00467-013-2724-0
- By:
- Publication type:
- Article
Population pharmacokinetics and pharmacodynamics of efmarodocokin alfa (IL-22Fc).
- Published in:
- Journal of Pharmacokinetics & Pharmacodynamics, 2024, v. 51, n. 2, p. 141, doi. 10.1007/s10928-023-09888-2
- By:
- Publication type:
- Article
Exposure‐Response Relationships for Pralsetinib in Patients with RET‐Altered Thyroid Cancer or RET Fusion‐Positive Nonsmall Cell Lung Cancer.
- Published in:
- Journal of Clinical Pharmacology, 2024, v. 64, n. 6, p. 685, doi. 10.1002/jcph.2409
- By:
- Publication type:
- Article
Population Pharmacokinetics of Tenecteplase in Patients With Acute Myocardial Infarction and Application to Patients With Acute Ischemic Stroke.
- Published in:
- Journal of Clinical Pharmacology, 2023, v. 63, n. 2, p. 197, doi. 10.1002/jcph.2164
- By:
- Publication type:
- Article
Population Pharmacokinetics and Exposure‐Response Relationship of Luspatercept, an Erythroid Maturation Agent, in Anemic Patients With β‐Thalassemia.
- Published in:
- Journal of Clinical Pharmacology, 2021, v. 61, n. 1, p. 52, doi. 10.1002/jcph.1696
- By:
- Publication type:
- Article
Population Pharmacokinetics and Exposure Response Analysis of Pomalidomide in Subjects With Relapsed or Refractory Multiple Myeloma From the Novel Combination Treatment of Pomalidomide, Bortezomib, and Low‐Dose Dexamethasone.
- Published in:
- Journal of Clinical Pharmacology, 2020, v. 60, n. 8, p. 1061, doi. 10.1002/jcph.1602
- By:
- Publication type:
- Article
Population Pharmacokinetics and Pharmacodynamics of Ontamalimab (SHP647), a Fully Human Monoclonal Antibody Against Mucosal Addressin Cell Adhesion Molecule‐1 (MAdCAM‐1), in Patients With Ulcerative Colitis or Crohn's Disease.
- Published in:
- Journal of Clinical Pharmacology, 2020, v. 60, n. 7, p. 903, doi. 10.1002/jcph.1590
- By:
- Publication type:
- Article
The Utility of a Population Approach in Drug-Drug Interaction Assessments: A Simulation Evaluation.
- Published in:
- Journal of Clinical Pharmacology, 2017, v. 57, n. 10, p. 1268, doi. 10.1002/jcph.921
- By:
- Publication type:
- Article
A disease model predicting placebo response and remission status of patients with ulcerative colitis using modified Mayo score.
- Published in:
- CTS: Clinical & Translational Science, 2023, v. 16, n. 11, p. 2310, doi. 10.1111/cts.13632
- By:
- Publication type:
- Article
Pharmacokinetics, Pharmacodynamics, and Exposure‐Response of Lanadelumab for Hereditary Angioedema.
- Published in:
- CTS: Clinical & Translational Science, 2020, v. 13, n. 6, p. 1208, doi. 10.1111/cts.12806
- By:
- Publication type:
- Article